Oculus Innovative Sciences (Nasdaq: OCLS) announced the European commercialization of Microcyn-based GramaDerm Solution and GramaDerm™ Hydrogel, approved for use in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE